Lung Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Lung Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Oct 25, 2018

---

• Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC). 
  Elamin Yasir Y et al. Clinical lung cancer 2018 Sep
• Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing.  
  Ikeda Sadakatsu et al. Cancer biology & therapy 2018 Oct 1-8
• Treatment Patterns by EGFR Mutation Status in Non-Small Cell Lung Cancer Patients in the USA: A Retrospective Database Analysis.  
  Aguilar Kathleen M et al. Advances in therapy 2018 Oct
• Circulating cell-free DNA- diagnostic and prognostic applications in personalized cancer therapy.  
  Oellerich M et al. Therapeutic drug monitoring 2018 Oct
• Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China.  
  Lu Shun et al. PloS one 2018 13(10) e0205827
• Budget Impact Analysis of Afatinib for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 19 Deletions or Exon 21 Substitution Mutations in a U.S. Health Plan.  
  Graham Jonathan et al. Journal of managed care & specialty pharmacy 2018 Jun 24(6) 544-553
• Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study.  
  Lin Chia-Chi et al. The Lancet. Respiratory medicine 2018 6(2) 107-116
• Rapid point-of-care testing for epidermal growth factor receptor gene mutations in patients with lung cancer using cell-free DNA from cytology specimen supernatants.  
  Asaka Shiho et al. International journal of oncology 2018 Jun 52(6) 2110-2118
• Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis.  
  Frieser Maia J et al. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2018 Oct
• Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.  
  Aggarwal Charu et al. JAMA oncology 2018 Oct